Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs.
about
Cellular and humoral immunity following Snow Mountain virus challengePorcine Rotaviruses: Epidemiology, Immune Responses and Control Strategies.Evaluation of combinatorial vaccines against anthrax and plague in a murine modelAn oral versus intranasal prime/boost regimen using attenuated human rotavirus or VP2 and VP6 virus-like particles with immunostimulating complexes influences protection and antibody-secreting cell responses to rotavirus in a neonatal gnotobiotic piViremia and nasal and rectal shedding of rotavirus in gnotobiotic pigs inoculated with Wa human rotavirus.A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model.Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus ΔVP8* subunit parenteral vaccinesCytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus.Chimaeric virus-like particles derived from consensus genome sequences of human rotavirus strains co-circulating in Africa.Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in miceHigh titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimenPathogenesis of a genogroup II human norovirus in gnotobiotic pigs.Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protectionVirus-specific intestinal IFN-gamma producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs.Rotavirus vaccines: how they work or don't work.Development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new P genotype.Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease.Development of a human rotavirus induced diarrhea model in Chinese mini-pigs.Development and Evaluation of CmeC Subunit Vaccine against Campylobacter jejuni.Rotavirus virus-like particles (RV-VLPs) vaccines: An update.Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.Construction of an artificial recombinant bicistronic plasmid DNA vaccine against porcine rotavirus.
P2860
Q24556676-AF8C69E7-1767-42CD-AB29-D224C6B65648Q30235130-F7FDAC8A-9A6F-4709-BC2F-F85EB020AB2DQ33283821-D2DB3F1E-F642-40D1-B38E-9882DEED13CBQ33725133-464AA4CA-67E9-4C22-B7AB-5490FC3089E4Q33755111-F0A98148-D753-4EE3-BC27-D1C32FBDBC72Q33889379-29725D96-5290-47B8-97F5-173248AD0208Q33923138-66D390EB-5061-46B7-AC0B-068B5B700DA9Q34233101-D6B0C7DE-6E9F-4D01-B884-543422E16409Q34275545-9FB776EC-4F77-46F6-9715-48BE1F28DC8DQ34510430-A8B8D554-544A-4D7A-9699-5F2CB7AE2A5CQ34601460-B0AFF950-C6B3-406A-97FC-F563A39E9BEAQ35139184-862800B9-4297-4B92-9255-BFD660AA1D40Q35542518-923551D2-3083-4C3C-823B-3B5380486F73Q36953220-12E69122-6789-4621-A20B-B52CA0728BEBQ37081817-93DCC920-C23E-4158-8D07-024C776A1898Q37743303-18B9666C-8620-4D3A-918F-560DFA1C8C6AQ38081968-B29DEE83-A9CC-4B83-88AE-E0A8941B17A1Q39175760-3D1B9033-CCAE-4F9C-A32A-31661AAB52A7Q39465922-0443196B-C62F-4AAC-B591-F4CA4733BFCFQ45326050-51D13428-E4CD-4092-BB96-CC6442158922Q47981695-7BF8BF77-70F4-4165-9B64-0015A56BC4B8Q50015475-727D4F78-A1F9-490D-B281-50E5D0270571
P2860
Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Protective immunity and antibo ...... ile toxin in gnotobiotic pigs.
@ast
Protective immunity and antibo ...... ile toxin in gnotobiotic pigs.
@en
type
label
Protective immunity and antibo ...... ile toxin in gnotobiotic pigs.
@ast
Protective immunity and antibo ...... ile toxin in gnotobiotic pigs.
@en
prefLabel
Protective immunity and antibo ...... ile toxin in gnotobiotic pigs.
@ast
Protective immunity and antibo ...... ile toxin in gnotobiotic pigs.
@en
P2093
P2860
P1433
P1476
Protective immunity and antibo ...... ile toxin in gnotobiotic pigs.
@en
P2093
M S Azevedo
T V Nguyen
P2860
P304
P356
10.1128/JVI.75.19.9229-9238.2001
P577
2001-10-01T00:00:00Z